Clinical Trials Sponsored by Guttorm Haugen
Total 1797 results
-
AmgenRecruitingAdvanced Solid Tumors | Kirsten Rat Sarcoma (KRAS) pG12C MutationUnited States, Italy, Taiwan, Spain, United Kingdom, Australia, Austria, Germany, Belgium, Japan, Netherlands, Korea, Republic of, Canada
-
AmgenRecruitingChemotherapy-induced ThrombocytopeniaUnited States, Spain, Turkey, Argentina, Greece, Austria, Brazil, Bulgaria, Chile, Colombia, Mexico, Peru, Poland, Portugal, Romania, Russian Federation, Ukraine, Hungary
-
AmgenRecruitingMelanoma | Herpetic InfectionUnited Kingdom, Austria, United States, Israel, Switzerland
-
AmgenActive, not recruitingMetastatic Castration-resistant Prostate CancerUnited States
-
AmgenAvailableSmall Cell Lung CancerUnited States, Brazil, Japan
-
AmgenCompletedOsteogenesis ImperfectaSpain, United States, Turkey, Austria, Germany, Greece, Hungary, Italy
-
AmgenActive, not recruitingAtherosclerotic Cardiovascular DiseaseUnited States, Belgium, Spain, China, Korea, Republic of, Australia, Netherlands, Austria, Czechia, Taiwan, Italy, Portugal, Greece, Hong Kong, Hungary, United Kingdom, France, Bulgaria, Germany, Finland, Japan, Sweden, Canada, Denmark, Icelan... and more
-
AmgenCompletedInflammatory DiseasesUnited Kingdom
-
AmgenTerminatedMantle Cell Lymphoma (MCL) | Follicular Lymphoma (FL) | Diffuse Large B-cell Lymphoma(DLBCL)United States, Canada, Germany, Belgium
-
AmgenActive, not recruitingMyasthenia GravisUnited States, Argentina, Belarus, Brazil, Canada, China, Denmark, France, Germany, India, Italy, Japan, Korea, Republic of, Poland, Russian Federation, Spain, Taiwan, Turkey, Ukraine
-
AmgenCompletedPsoriasisUnited States, Belgium, Italy, France, Germany, Puerto Rico, Canada
-
AmgenCompleted
-
AmgenCompletedLupus Erythematosus, SystemicUnited States, Spain, Serbia, Mexico, Poland, Greece, Argentina, India, Russian Federation, Taiwan, Ukraine
-
AmgenCompletedAlopecia AreataUnited States, Canada
-
AmgenActive, not recruitingRelapsed or Refractory Multiple Myeloma | Relapsed or Refractory Acute Myeloid LeukemiaUnited States, Australia, Japan, Germany, Canada
-
AmgenActive, not recruitingKRAS p.G12C Mutant Advanced Solid TumorsUnited States, France, Canada, Spain, Belgium, Korea, Republic of, Austria, Australia, Hungary, Greece, Germany, Japan, Romania, Switzerland, Brazil, Portugal
-
AmgenActive, not recruitingCoronary Heart Disease (CHD)Canada, France, United States, Spain, United Kingdom, Korea, Republic of, Netherlands, Austria, Australia, Czechia, Taiwan, Finland, Hungary, Italy, Poland, Greece, Germany, Brazil, Latvia, Denmark, Mexico, Russian Federation, Bulgaria and more
-
AmgenCompletedAdvanced Solid TumorsCanada, United States, Belgium, Spain, Brazil, Korea, Republic of, Poland, Singapore, Taiwan, Japan, United Kingdom, Australia, Turkey
-
AmgenActive, not recruitingRelapsed or Refractory Multiple MyelomaUnited States, Spain, Germany, France, Italy, Denmark, Greece, Estonia
-
AmgenActive, not recruiting
-
AmgenActive, not recruitingPsoriasisBelgium, Spain, United States, Czechia, Italy, Russian Federation, Canada, France, Israel
-
AmgenCompletedNon-Hodgkin's LymphomaUnited States, Australia, Italy, United Kingdom, Germany, France
-
AmgenActive, not recruitingChemotherapy-induced ThrombocytopeniaUnited States, France, Austria, Hungary, Russian Federation, Romania, Spain, Turkey, Greece, Italy, Bulgaria, Canada, Portugal, Argentina, Poland, Mexico, Colombia, Peru, Brazil, Ukraine
-
AmgenCompletedMultiple MyelomaUnited States, Australia
-
AmgenCompletedHealthy VolunteersUnited States
-
AmgenActive, not recruitingNon-squamous Non-small Cell Lung Cancer | Epithelial Ovarian Cancer | Claudin 6-positive Advanced/Metastatic Malignant Solid TumorsUnited States, Australia, Switzerland
-
AmgenCompletedEvaluate the Safety and Efficacy of Denosumab in Pediatric Subjects With | Glucocorticoid-induced OsteoporosisUnited States, Bulgaria, Turkey, Italy, Australia, Belgium, Canada, Colombia, India, Mexico, Peru, Russian Federation, Ukraine
-
AmgenTerminatedPsoriasisUnited States, Belgium, Spain, Czechia, Canada, Italy, Israel, France, Netherlands, Russian Federation
-
AmgenTerminatedChronic Graft Versus Host Disease cGVHDUnited States, Japan, France, Belgium
-
AmgenCompletedNon-alcoholic Fatty Liver DiseaseUnited States
-
AmgenCompletedAdvanced Solid TumorsUnited States, Belgium, Spain, Australia
-
AmgenActive, not recruitingSmall Cell Lung CancerUnited States, Belgium, Austria, Singapore, Taiwan, Japan
-
AmgenCompletedMigraineUnited States
-
AmgenCompletedPregnancyUnited States
-
AmgenTerminatedActive Systemic Lupus ErythematosusKorea, Republic of, United States, Taiwan, Canada, Spain, Italy, Mexico, Japan, Turkey, Austria, Greece, Colombia, Switzerland, Poland, France, Bulgaria, Hong Kong, Russian Federation, Chile
-
AmgenActive, not recruitingSquamous-Cell Non-Small-Cell Lung CancerFrance, Belgium, Spain, United States, Taiwan, Korea, Republic of, Japan, Poland
-
AmgenCompletedHealthy ParticipantsUnited States
-
AmgenCompletedObesityUnited States
-
AmgenTerminated
-
AmgenCompleted
-
AmgenCompletedAnti-neutrophil Cytoplasmic Antibody-associated VasculitisUnited States
-
AmgenCompleted
-
AmgenCompletedHealthy ParticipantsUnited States
-
AmgenTerminated
-
AmgenCompleted
-
AmgenCompletedChronic Graft-versus-host Disease (cGVHD)United States
-
AmgenCompletedParoxysmal Nocturnal HemoglobinuriaSpain, Italy, United States, Norway, Czechia, United Kingdom, Slovenia, Netherlands, Turkey, Portugal, Finland, France, Ireland, Sweden
-
AmgenTerminatedRelapsed/Refractory Acute Myeloid Leukemia (AML)United States, Korea, Republic of, Australia, Japan, Germany, Canada